Myonex helped Carthera maintain the planned study timeline for the Phase III SONOBIRD_SC9-GMB-03 study by redesigning supply flows and combining local execution with centralized oversight.

Myonex is an industry leader in global clinical trial supply and pharmaceutical commercial services. Our suite of integrable services and solutions helps pharmaceutical, biotech, and CRO partners advance medicine by reducing time, costs, and complexity. With locations in the US, Germany, UK, and France, our comprehensive, client-focused approach, coupled with expert project management, ensures seamless execution across regions, optimizes supply chain efficiency, and adapts to evolving trial or project needs while delivering quality, flexibility, and global scale. Learn more at www.myonex.com.